Healthtech funding in H1 2015
European Healthtech startup funding raised during H1 2015.
In H1 2015, 81 European Healthtech companies closed 87 funding rounds and raised €482M in equity funding (excluding debt and grants), up 24.8% versus H1 2014. Debt rounds added €260k. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€482M
+24.8% vs H1 2014 · excl. debt & grants · +€260k debt
Funding rounds
87
+24.3% vs H1 2014
Companies
81
Top country
Switzerland
Rank among sectors
#8
4.7% of sector funding
Debt financing
€260k
0.1% of total
Top-10 round share
60.3%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H1 2015 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €102M | 16 |
| Feb | €873k | 6 |
| Mar | €79M | 15 |
| Apr | €171M | 19 |
| May | €81M | 14 |
| Jun | €56M | 17 |
Top countries
by € raisedHealthtech — top countries by capital, H1 2015 — interactive chart.
Data table
| Healthtech — top countries by capital, H1 2015 | |
|---|---|
| Switzerland | €88M |
| UK | €73M |
| Germany | €66M |
| Israel | €60M |
| France | €57M |
| Denmark | €23M |
| Ireland | €23M |
| Sweden | €19M |
Stage mix
by € raisedHealthtech — stage mix, H1 2015 — interactive chart.
Data table
| Healthtech — stage mix, H1 2015 | |
|---|---|
| Series B | €170M |
| Series D+ | €85M |
| Series A | €74M |
| Growth/Late | €68M |
| Seed | €36M |
| Early VC | €33M |
| Other | €18M |
| Grant | €7.4M |
| Debt | €260k |
Exits & M&A
7 Acquisition · 2 Buyout9 exits · €295M disclosed.
| Dezima Pharma | Acquisition | Mar 2015 | €273M |
| AMO Pharma | Buyout | Jun 2015 | €23M |
Top deals
largest disclosed rounds in H1 2015| Company | Stage | Date | Amount |
|---|---|---|---|
| CRISPR Therapeutics | Series B | Apr 2015 | €59M |
| CureVac | Series D+ | Mar 2015 | €46M |
| Kymab | Series B | May 2015 | €45M |
| Echosens | Growth/Late | Apr 2015 | €31M |
| Veryan Medical | Series B | Jan 2015 | €23M |
| Advanced Accelerator Applications | Growth/Late | Jun 2015 | €23M |
| Orphazyme | Series B | Jan 2015 | €20M |
| GenKyoTex | Series D+ | Jan 2015 | €17M |
| EarlySense | Series D+ | Jan 2015 | €16M |
| Allecra Therapeutics | Series A | Apr 2015 | €15M |
| BONESUPPORT | Growth/Late | Apr 2015 | €13M |
| Onbone | Early VC | Apr 2015 | €10M |
| Vittamed | Other | Apr 2015 | €9.3M |
| docplanner | Series B | May 2015 | €8.9M |
| TalkSpace | Series A | May 2015 | €8.5M |
Top investors
most active in H1 2015, by deal count- High-Tech Gründerfonds (HTGF)3 deals
- Imprimatur Capital3 deals
- BioMedPartners2 deals
- Boehringer Ingelheim Venture Fund2 deals
- Bpifrance2 deals
- Cabiedes & Partners2 deals
- Faraday Venture Partners2 deals
- Imperial Innovations Limited2 deals
- OurCrowd2 deals
- SEEDIL2 deals